List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #14,921 to #14,970.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. DCMO → Capillary malformation#Cutaneous and/or mucosal CM (“port-wine” stain)
  2. DCPIP → Dichlorphenolindophenol
  3. DC cardioversion → Cardioversion
  4. DD → Delusional disorder
  5. DDAT / Dore → Dore (dyslexia treatment)
  6. DDAVP → Desmopressin (patient information)
  7. DDAVP Nasal → Desmopressin (patient information)
  8. DDAVP Rhinal Tube → Desmopressin (patient information)
  9. DDB2 gene → DDB2
  10. DDD → DDT
  11. DDH → Hip dysplasia (human)
  12. DDIT3 gene → DNA damage-inducible transcript 3
  13. DDS → Doctor of Dental Surgery
  14. DEAR-MI → Dethrombosis To Enhance Acute Reperfusion In Myocardial Infarction
  15. DEBATE → Doppler Endpoints Balloon Angioplasty Trial Europe
  16. DEBATE II → Doppler Endpoints Balloon Angioplasty Trial Europe-2
  17. DEBUT → Defibrillator Versus Beta-Blockers For Unexplained Death In Thailand
  18. DECLARE-DIABETES → Drug-Eluting Stenting Followed By Cilostazol Treatment Reduces Late Restenosis In Patients With Diabetes Mellitus
  19. DECOPI → Randomized Trial Of Occluded Artery Angioplasty After Acute Myocardial Infarction
  20. DECREASE-V → Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo-V
  21. DECREASE III → Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo III
  22. DEDICATION: Distal Protection Study → Drug Elution And Distal Protection In St-Elevation Myocardial Infarction
  23. DEDICATION: Stent Study → Drug Elution And Distal Protection In Acute Myocardial Infarction
  24. DEFER → Deferral Versus Performance Of Ptca In Patients Without Documented Ischemia
  25. DEFINE STUDY → Anacetrapib, DEFINE TRIAL
  26. DEFINITE → Defibrillators In Nonischemic Cardiomyopathy Treatment Evaluation
  27. DEFN → Balkan nephropathy
  28. DEFUSE → Diffusion-Weighted Imaging Evaluation For Understanding Stroke Evaluation
  29. DEK gene → DEK (gene)
  30. DELIDOSE → Estradiol
  31. DELTA MI → Direct Inhibition Of Δ-Protein Kinase C Enzyme To Limit Total Infarct Size In Acute Mi
  32. DEMENTIA → Dementia
  33. DENV → Dengue virus
  34. DENV-1 → Dengue virus
  35. DENV-2 → Dengue virus
  36. DENV-3 → Dengue virus
  37. DENV-4 → Dengue virus
  38. DENV–1 → Dengue virus
  39. DENV–2 → Dengue virus
  40. DENV–3 → Dengue virus
  41. DENV–4 → Dengue virus
  42. DERMESTRIL SEPTEM → Estradiol
  43. DES-DIABETES → A Randomized Comparison Of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation In Patients With Diabetes Mellitus
  44. DESTINI-CFR → Doppler Endpoints Stenting International Investigation - Coronary Flow Reserve
  45. DETAIL → Diabetics Exposed To Telmisartan And Enalapril
  46. DEXA scan → Dual energy X-ray absorptiometry
  47. DEXMETHYLPHENIDATE (patient information) → DEXMETHYLPHENIDATE#ptcounselling information
  48. DFA-TP → Direct fluorescent antibody
  49. DFI → Diabetic foot medical therapy#Diabetic Foot Infection
  50. DFSP → Dermatofibrosarcoma protuberans

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"